Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Silverstein

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Lupus|October 1, 1996
Antiphospholipid antibodies activate vascular endothelial cellsR Simantov, S K Lo, A Gharavi, et al.
The Journal of Cell Biology|August 11, 1997
CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cellsD W Dawson, S F Pearce, R Zhong, et al.
The Journal of Biological Chemistry|July 27, 2000
Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout miceC T Coburn, F F Knapp, M Febbraio, et al.
The Journal of Biological Chemistry|June 26, 1999
A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolismM Febbraio, N A Abumrad, D P Hajjar, et al.
Molecular and Cellular Biochemistry|December 14, 2002
The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36M Febbraio, E Guy, C Coburn, et al.
The Journal of Experimental Medicine|October 9, 1998
Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytesM L Albert, S F Pearce, L M Francisco, et al.
Journal of Lipid Research|April 29, 2000
Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gammaJ Feng, J Han, S F Pearce, et al.
The Journal of Clinical Investigation|November 1, 1995
Activation of cultured vascular endothelial cells by antiphospholipid antibodiesR Simantov, J M LaSala, S K Lo, et al.
Molecular Pharmacology|February 3, 1999
Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeatD W Dawson, O V Volpert, S F Pearce, et al.
Leukemia Research|July 6, 2004
The second international congress on myeloproliferative and myelodysplastic syndromesR T Silver, J M Bennett, M Deininger, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Lupus|October 1, 1996
Antiphospholipid antibodies activate vascular endothelial cellsR Simantov, S K Lo, A Gharavi, et al.
The Journal of Cell Biology|August 11, 1997
CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cellsD W Dawson, S F Pearce, R Zhong, et al.
The Journal of Biological Chemistry|July 27, 2000
Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout miceC T Coburn, F F Knapp, M Febbraio, et al.
The Journal of Biological Chemistry|June 26, 1999
A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolismM Febbraio, N A Abumrad, D P Hajjar, et al.
Molecular and Cellular Biochemistry|December 14, 2002
The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36M Febbraio, E Guy, C Coburn, et al.
The Journal of Experimental Medicine|October 9, 1998
Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytesM L Albert, S F Pearce, L M Francisco, et al.
Journal of Lipid Research|April 29, 2000
Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gammaJ Feng, J Han, S F Pearce, et al.
The Journal of Clinical Investigation|November 1, 1995
Activation of cultured vascular endothelial cells by antiphospholipid antibodiesR Simantov, J M LaSala, S K Lo, et al.
Molecular Pharmacology|February 3, 1999
Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeatD W Dawson, O V Volpert, S F Pearce, et al.
Leukemia Research|July 6, 2004
The second international congress on myeloproliferative and myelodysplastic syndromesR T Silver, J M Bennett, M Deininger, et al.
Pageof 8